Molecular Partners AG (MOLN) — Capital Reinvestment Ratio
Molecular Partners AG (MOLN) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow (CHF163.56 Million) in capital expenditures (CHF380.00K). Check MOLN tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Molecular Partners AG Capital Reinvestment Ratio (2015–2022)
This chart tracks Molecular Partners AG's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Molecular Partners AG (MOLN) cash flow conversion.
Annual Capital Reinvestment Ratio for Molecular Partners AG (2015–2022)
Year-by-year Capital Reinvestment Ratio for Molecular Partners AG from 2015 to 2022. See MOLN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | CHF118.57 Million | CHF1.42 Million | ▼ -77.2% |
| 2015 | 0.05x | CHF26.50 Million | CHF1.39 Million | — |